By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
By Genevieve Meehan
May 4, 2022
Following the resolution of a year-long lawsuit, OMMA is moving forward with implementing a statewide track-and-trace system to monitor all medical marijuana and medical marijuana products being grown, processed, transported, tested, and sold in the State of Oklahoma.
By Michelle Bodian, Jace Pohlman
May 2, 2022
Your cannabis business just received an EHS audit. Here are some post-audit tips to help you achieve compliance now and in the future.
By Jason Adelstone
Apr 27, 2022
A recent paper by Kenzi Riboulet-Zemouli argues that the 1961 Single Convention on Narcotic Drugs already allows for the regulation of Non-Medical cannabis. This premise, unfortunately, is just incorrect.
By Marc Ross
Apr 22, 2022
In a guest column for Cannabis Business Times, VS's head of Impact and ESG, Marc Ross, discusses the legal risks associated with greenwashing and the steps cannabis companies can take to avoid them.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.